Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253 · see citing works

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053 · see citing works

Drug-induced prolongation of the QT interval

Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965 · see citing works

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,963 · see citing works

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682 · see citing works

Risk Stratification in the Long-QT Syndrome

Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456 · see citing works

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353 · see citing works

Approaches to Sudden Death from Coronary Heart Disease

Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258 · see citing works

Atypical antipsychotic drugs and the risk of sudden cardiac death

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194 · see citing works

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012 · see citing works

Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs

Makkar, R. (1993) · JAMA · doi:10.1001/jama.270.21.2590 · Cited by 972 · see citing works

The long QT syndrome. Prospective longitudinal study of 328 families.

Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J. W., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 966 · see citing works

Untitled work

Kligfield (2007) · doi:10.1161/circulationaha.106.180200 · Cited by 802 · see citing works

Influence of the Genotype on the Clinical Course of the Long-QT Syndrome

Zaręba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 749 · see citing works

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Antzelevitch, C. N., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Diego, J. M. D., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 674 · see citing works

Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences

Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664 · see citing works

Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes

Roden, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 662 · see citing works

Mechanism of the Cardiotoxic Actions of Terfenadine

Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646 · see citing works

Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses

Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C., Swiryn, S., & Van Hare, G. F. (2004) · Circulation · doi:10.1161/01.cir.0000145144.56673.59 · Cited by 609 · see citing works

Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes

Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M. S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 551 · see citing works

Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia

Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 523 · see citing works

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 489 · see citing works

Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patients

Kay, G. N., Plumb, V. J., Arciniegas Joaquin, G., Henthorn, R. W., & L, W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463 · see citing works

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P. G., Verheugt, F. W. A., Gersh, B. J., McCabe, C. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.724880 · Cited by 444 · see citing works

Extracellular Potassium Modulation of Drug Block of IKr

Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 428 · see citing works

Torsade de Pointes Associated with Very-High-Dose Methadone

Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00010 · Cited by 424 · see citing works

Long QT Syndrome in Adults

Sauer, A. J., Moss, A. J., McNitt, S. A., Peterson, D. R., Zaręba, W., Robinson, J. L., Qi, M., Goldenberg, I., Hobbs, J. B., Ackerman, M. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.057 · Cited by 417 · see citing works

[Ventricular tachycardia with 2 variable opposing foci].

Dessertenne, F. (1966) · PubMed · Cited by 414 · see citing works

Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one

Viskin, S., Rosovski, U., Sands, A. J., Chen, E., Kistler, P. M., Kalman, J. M., Chávez, L. R., Torres, P. I., Cruz, F. E. S., Centurión, O. A., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.02.011 · Cited by 404 · see citing works

Rate-corrected QT interval: Techniques and limitations

Funck‐Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401 · see citing works

Increased Short-Term Variability of Repolarization Predicts d -Sotalol–Induced Torsades de Pointes in Dogs

Thomsen, M. B., Verduyn, S. C., Štengl, M., Beekman, J. D. M., de Pater, G., van Opstal, J. M., Volders, P. G. A., & Vos, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000145162.64183.c8 · Cited by 361 · see citing works

Drug‐Induced Torsades de Pointes and Implications for Drug Development

Fenichel, R. R., Malík, M., Antzelevitch, C. N., Sanguinetti, M. C., Roden, D. M., Priori, S. G., Ruskin, J. N., Lipicky, R. J., Cantilena, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 343 · see citing works

QTc Interval Screening in Methadone Treatment

Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 334 · see citing works

Long QT syndrome: reduced repolarization reserve and the genetic link

Roden, D. M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 318 · see citing works

Accurate electrocardiographic assessment of the QT interval: Teach the tangent

Postema, P. G., de Jong, J. S. S. G., van der Bilt, I. A. C., & Wilde, A. A. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.037 · Cited by 317 · see citing works

Cellular mechanisms underlying the long QT syndrome

Antzelevitch, C. N., & Shimizu, W. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200201000-00007 · Cited by 313 · see citing works

Assessing predictors of drug-induced torsade de pointes

Belardinelli, L., Antzelevitch, C., & Vos, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.002 · Cited by 303 · see citing works

Unique Topographical Distribution of M Cells Underlies Reentrant Mechanism of Torsade de Pointes in the Long-QT Syndrome

Akar, F. G., Yan, G., Antzelevitch, C. N., & ROSENBAUM, D. S. (2002) · Circulation · doi:10.1161/hc1002.105231 · Cited by 301 · see citing works

Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias

Napolitano, C., Schwartz, P. J., Brown, A. M., Ronchetti, E., Bianchi, L. K., Pinnavaia, A., Aquaro, G. D., & Priori, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300 · see citing works

Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT Syndrome

Ackerman, M. J., Tester, D. J., Jones, G. S., Will, M. L., Burrow, C. R., & Curran, M. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1479 · Cited by 295 · see citing works

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1 , and KCNE2 in drug-induced long QT syndrome patients

Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze‐Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 279 · see citing works

Torsade de Pointes Due to Noncardiac Drugs

Zeltser, D., Justo, D., Halkin, A., Prokhorov, V., Heller, K., & Viskin, S. (2003) · Medicine · doi:10.1097/01.md.0000085057.63483.9b · Cited by 273 · see citing works

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data

Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261 · see citing works

Genetics of acquired long QT syndrome

Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 258 · see citing works

The Morphology of the QT Interval Predicts Torsade de Pointes During Acquired Bradyarrhythmias

Topilski, I., Rogowski, O., Rosso, R., Justo, D., Copperman, Y., Glikson, M., Belhassen, B., Hochenberg, M., & Viskin, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.058 · Cited by 236 · see citing works

Drug-induced long QT and torsade de pointes: recent advances

Kannankeril, P. J., & Roden, D. M. (2006) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 230 · see citing works

Is Gender a Risk Factor for Adverse Drug Reactions?

Drici, M., & ment, N. C. (2001) · Drug Safety · doi:10.2165/00002018-200124080-00002 · Cited by 227 · see citing works

Female Gender as a Risk Factor for Drug-Induced Cardiac Arrhythmias: Evaluation of Clinical and Experimental Evidence

Ebert, S. N., Liu, X., & Woosley, R. L. (1998) · Journal of Women s Health · doi:10.1089/jwh.1998.7.547 · Cited by 223 · see citing works

A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y

Plant, L. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25618 · Cited by 216 · see citing works

Electrophysiological Mechanism of the Characteristic Electrocardiographic Morphology of Torsade de Pointes Tachyarrhythmias in the Long-QT Syndrome

El‐Sherif, N., Chinushi, M., Caref, E. B., & Restivo, M. (1997) · Circulation · doi:10.1161/01.cir.96.12.4392 · Cited by 215 · see citing works

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

Carlsson, L. M. S., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213 · see citing works

Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Mason, J. W., Hondeghem, L. M., & Katzung, B. G. (1984) · Circulation Research · doi:10.1161/01.res.55.3.278 · Cited by 211 · see citing works

Cardiac Actions of Erythromycin

Drici, M., Knollmann, B. C., Wang, W.-X., & Woosley, R. L. (1998) · JAMA · doi:10.1001/jama.280.20.1774 · Cited by 197 · see citing works

Normalization of Acquired QT Prolongation in Humans by Intravenous Potassium

Choy, A. M., Lang, C. C., Chomsky, D. M., Rayos, G. H., Wilson, J. R., & Roden, D. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2149 · Cited by 196 · see citing works

Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome

Wu, L., Shryock, J. C., Song, Y., Li, Y., Antzelevitch, C. N., & Belardinelli, L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066100 · Cited by 193 · see citing works

T wave alternans in idiopathic long QT syndrome

Zaręba, W., Moss, A. J., le Cessie, S., & Hall, W. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90653-x · Cited by 185 · see citing works

Effect of Clinical Phenotype on Yield of Long QT Syndrome Genetic Testing

Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.056 · Cited by 184 · see citing works

The long QT syndrome family of cardiac ion channelopathies: A HuGE review

Modell, S. M., & Lehmann, M. H. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000204468.85308.86 · Cited by 176 · see citing works

Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias

Yang, T., Snyders, D. J., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 172 · see citing works

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype

von Bahr, C., Movin, G., Nordin, C., Lidén, A., Hammarlund‐Udenaes, M., Hedberg, A. L., Ring, H., & Sjöqvist, F. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.22 · Cited by 158 · see citing works

Ibutilide

Murray, K. T. (1998) · Circulation · doi:10.1161/01.cir.97.5.493 · Cited by 155 · see citing works

Clinical safety profile of sotalol in patients with arrhythmias

Soyka, L. F., Wirtz, C., & Spangenberg, R. B. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90207-h · Cited by 153 · see citing works

Concomitant Risk Factors in Reports of Torsades de Pointes Associated with Macrolide Use: Review of the United States Food and Drug Administration Adverse Event Reporting System

Shaffer, D., Singer, S., Korvick, J. A., & Honig, P. K. (2002) · Clinical Infectious Diseases · doi:10.1086/340861 · Cited by 151 · see citing works

Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter

Kowey, P. R., VanderLugt, J. T., & Luderer, J. R. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00566-8 · Cited by 133 · see citing works

Torsade de Pointes Associated with the Use of Intravenous Haloperidol

Wilt, J. L., Minnema, A. M., Johnson, R. F., & Rosenblum, A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00007 · Cited by 126 · see citing works

AHA Scientific Statement

Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C. E., Swiryn, S., & Hare, G. F. V. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200503000-00003 · Cited by 125 · see citing works

How Really Rare Are Rare Diseases?:

Schwartz, P. J., Priori, S. G., & Napolitano, C. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03339.x · Cited by 124 · see citing works

Role of SCN5A Y1102 Polymorphism in Sudden Cardiac Death in Blacks

Burke, A., Creighton, W., Mont, E., Li, L., Hogan, S., Kutys, R., Fowler, D., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.482760 · Cited by 118 · see citing works

Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study

Houltz, B., Darpö, B., Edvardsson, N. G., Blomström, P., Brachmann, J., Crijns, H. J. G. M., Jensen, S. M., Svernhage, E., Vallin, H., & Swedberg, K. B. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00150.x · Cited by 117 · see citing works

In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs

Bruin, M. L. D., Langendijk, P. N. J., Koopmans, R. P., Wilde, A. A. M., Leufkens, H. G. M., & Hoes, A. W. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02722.x · Cited by 113 · see citing works

Does Low-dose Droperidol Administration Increase the Risk of Drug-induced QT Prolongation and Torsade de Pointes in the General Surgical Population?

Nuttall, G. A., Eckerman, K. M., Jacob, K. A., Pawlaski, E. M., Wigersma, S. K., Marienau, M. E. S., Oliver, W. C., Narr, B. J., & Ackerman, M. J. (2007) · Anesthesiology · doi:10.1097/01.anes.0000281893.39781.64 · Cited by 103 · see citing works

Drug Therapy For Torsade de Pointes

Banai, S., & Tzivoni, D. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01224.x · Cited by 98 · see citing works

QTc Interval in the Assessment of Cardiac Risk

Elming, H., Brendorp, B., Køber, L., Sahebzadah, N., & Torp-Petersen, C. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016345412555 · Cited by 90 · see citing works

Drug induced QT prolongation.

Zaręba, W. (2007) · PubMed · Cited by 90 · see citing works

Effects of low potassium or magnesium concentrations on isolated cardiac tissue

Roden, D. M., & Iansmith, D. H. S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90128-8 · Cited by 90 · see citing works

Amiodarone and Torsade de Pointes

Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 90 · see citing works

Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug–associated torsades de pointes

Lehtonen, A., Fodstad, H., Laitinen-Forsblom, P. J., Toivonen, L. K., KONTULA, K. K., & Swan, H. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.01.019 · Cited by 89 · see citing works

Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarization

Roden, D. M. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_h.56 · Cited by 87 · see citing works

Drug‐induced torsades de pointes: a review of the Swedish pharmacovigilance database

Åström‐Lilja, C., Odeberg, J. M., Ekman, E., & Hägg, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1607 · Cited by 86 · see citing works

Thorough QT/QTc Not So Thorough: Removes Torsadogenic Predictors from the T‐Wave, Incriminates Safe Drugs, and Misses Profibrillatory Drugs

Hondeghem, L. M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00347.x · Cited by 85 · see citing works

Drug-induced torsades de pointes: The evolving role of pharmacogenetics

Fitzgerald, P., & Ackerman, M. J. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.08.007 · Cited by 83 · see citing works

How to correct the QT interval for the effects of heart rate in clinical studies

Davey, P. P. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00008-x · Cited by 80 · see citing works

QT lengthening and life-threatening arrhythmias associated with fexofenadine

Pinto, Y. M., Gelder, I. C. V., Heeringa, M. J., & Crijns, H. J. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01009-0 · Cited by 78 · see citing works

Risk Factors and Predictors of Torsade de Pointes Ventricular Tachycardia in Patients With Left Ventricular Systolic Dysfunction Receiving Dofetilide

Pedersen, H. S., Elming, H., Seibæk, M., Burchardt, H., Brendorp, B., Torp-Pedersen, C. T., & Køber, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.020 · Cited by 74 · see citing works

Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors

Justo, D., Prokhorov, V., Heller, K., & Zeltser, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00469.x · Cited by 72 · see citing works

Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest

Tarabar, A. F., Hoffman, R. S., & Nelson, L. S. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160963 · Cited by 72 · see citing works

Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome

Norstrand, D. W. V., Tester, D. J., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.012 · Cited by 67 · see citing works

Torsades de Pointes Induced by Erythromycin

Gitler, B., Berger, L. S., & Buffa, S. D. (1994) · CHEST Journal · doi:10.1378/chest.105.2.368 · Cited by 61 · see citing works

Life‐threatening ventricular tachycardia due to liquorice‐induced hypokalaemia

Eriksson, J. W., Carlberg, B., & Hillörn, V. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00476.x · Cited by 58 · see citing works

Practice Standards for ECG Monitoring in Hospital Settings: Executive Summary and Guide for Implementation

Drew, B. J., & Funk, M. (2006) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2006.01.007 · Cited by 58 · see citing works

Individual Patterns of QT/RR Relationship

Batchvarov, V. N., & Malík, M. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016393328485 · Cited by 56 · see citing works

Frequency of high‐risk use of QT‐prolonging medications

LaPointe, N. M. A., Curtis, L. H., Chan, K. A., Kramer, J. M., Lafata, J. E., Gurwitz, J. H., Raebel, M. A., & Platt, R. G. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1155 · Cited by 55 · see citing works

What Is the Minimal Pacing Rate that Prevents Torsades de Pointes? Insights from Patients with Permanent Pacemakers

Pinski, S. L., Eguía, L. E., & Trohman, R. G. (2002) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2002.01612.x · Cited by 54 · see citing works

Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes

Mank-Seymour, A. R., Richmond, J., Wood, L. S., Reynolds, J. M., Fan, Y.-T., Warnes, G. R., Milos, P. M., & Thompson, J. F. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.08.020 · Cited by 54 · see citing works

Persistent Atrial Fibrillation Is Associated With Reduced Risk of Torsades de Pointes in Patients With Drug-Induced Long QT Syndrome

Darbar, D., Kimbrough, J., Jawaid, A., McCray, R., Ritchie, M. D., & Roden, D. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.066 · Cited by 49 · see citing works

Torsade de pointes ventricular tachycardia a complication of disopyramide shared with quinidine

Wald, R. W., Waxman, M. B., & Colman, J. M. (1981) · Journal of Electrocardiology · doi:10.1016/s0022-0736(81)80013-1 · Cited by 48 · see citing works

Relation of QT Interval Measurements to Evolving Automated Algorithms from Different Manufacturers of Electrocardiographs

Kligfield, P., Hancock, E. W., Helfenbein, E. D., Dawson, E. J., Cook, M. A., Lindauer, J. M., Zhou, S., & Xue, J. Q. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.060 · Cited by 48 · see citing works

Clinical Evaluation of Adverse Effects During Bepridil Administration for Atrial Fibrillation and Flutter

Yasuda, M., Nakazato, Y., Sasaki, A., Kawano, Y., Nakazato, K., Tokano, T., & Daida, H. (2006) · Circulation Journal · doi:10.1253/circj.70.662 · Cited by 48 · see citing works

Torsade de pointes induced by N-Acetylprocainamide

Chow, M. J., Piergies, A. A., Bowsher, D. J., Murphy, J. J., Kushner, W., Ruo, T. I., Asada, A., Talano, J. V., & Atkinson, A. J. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80111-4 · Cited by 44 · see citing works

Torsades de pointes induced by antibiotics

Justo, D., & Zeltser, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.12.003 · Cited by 42 · see citing works

Hypocalcemic torsades de pointes

Akiyama, T., Batchelder, J. E., Worsman, J., Moses, H. W., & Jedlinski, M. (1989) · Journal of Electrocardiology · doi:10.1016/0022-0736(89)90026-5 · Cited by 42 · see citing works

Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States

Singh, B. N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90962-x · Cited by 37 · see citing works

Concomitant Use of Antipsychotics and Drugs That May Prolong the QT Interval

Roe, C. M., Odell, K. W., & Henderson, R. R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00013 · Cited by 37 · see citing works

An algorithm for continuous real-time QT interval monitoring

Helfenbein, E. D., Zhou, S., Lindauer, J. M., Field, D. Q., Gregg, R. E., Wang, J. J., Kresge, S. S., & Michaud, F. P. (2006) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2006.05.018 · Cited by 36 · see citing works

Torsades de pointes: Prevention and therapy

Keren, A., & Tzivoni, D. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029778 · Cited by 28 · see citing works

Prophylactic Magnesium to Decrease the Arrhythmogenic Potential of Class III Antiarrhythmic Agents in a Rabbit Model

White, C. M., Xie, J., Chow, M. S. S., & Kluger, J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.635.31528 · Cited by 28 · see citing works

Ciprofloxacin- and Hypocalcemia-Induced Torsade de Pointes Triggered by Hemodialysis

Daya, S. K., Gowda, R. M., & Khan, I. A. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200401000-00014 · Cited by 27 · see citing works

Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration

Nakasone, H., Sugama, R., Sakugawa, H., Matayoshi, R., Miyagi, T., Maeshiro, T., Yamashiro, T., Higa, F., Hokama, A., Kinjo, F., et al. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170061 · Cited by 25 · see citing works

Acquired long QT syndrome: Risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I

Raviña, T., Raviña, P., & Gutiérrez, J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.084 · Cited by 24 · see citing works

Preventing Torsades de Pointes by Careful Cardiac Monitoring in Hospital Settings

Sommargren, C. E., & Drew, B. J. (2007) · AACN Advanced Critical Care · doi:10.4037/15597768-2007-3007 · Cited by 23 · see citing works

Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports

Justo, D., & Zeltser, D. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01278.x · Cited by 23 · see citing works

Management of Ventricular Dysrhythmia Secondary to Trazodone Overdose

Chung, K.-J., Wang, Y.-C. L., Liu, B., & Supernaw, R. B. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.02.036 · Cited by 22 · see citing works

Block of IKs by the Diuretic Agent Indapamide Modulates Cardiac Electrophysiological Effects of the Class III Antiarrhythmic Drug dl-Sotalol

Fiset, C., Drolet, B., Hamelin, B. A., & Turgeon, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36991-5 · Cited by 20 · see citing works

Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia

Dı́az-Castro, Ó., Puchol, A., Almendral, J. M., Torrecilla, E. G., Arenal, Á., & Martínez‐Sellés, M. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2003.10.003 · Cited by 19 · see citing works

Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome

Kawabata, M., Hirao, K., Sasaki, T., Sakurai, K., Inagaki, H., Hachiya, H., & Isobe, M. (2008) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2007.09.009 · Cited by 18 · see citing works

Preventing Torsades de Pointes by Careful Cardiac Monitoring in Hospital Settings

Sommargren, C. E., & Drew, B. J. (2007) · AACN Advanced Critical Care · doi:10.1097/01.aacn.0000284429.45534.4a · Cited by 13 · see citing works

[The value of magnesium in intensive care medicine].

Lüderitz, B., & Manz, M. G. (1994) · PubMed · Cited by 8 · see citing works

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175 · see citing works

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036 · see citing works

Heart disease and stroke statistics-2018 update: a report from the american heart association

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146 · see citing works

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

Authors Task Force Members, Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. D., Ford, I., González‐Juanatey, J. R., Görenek, B., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,650 · see citing works

Magnesium in Prevention and Therapy

Gröber, U., Schmidt, J., & Kisters, K. (2015) · Nutrients · doi:10.3390/nu7095388 · Cited by 1,061 · see citing works

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Herrmann, J., Lenihan, D. J., Armenian, S. H., Barac, A., Blaes, A. H., Cardinale, D. M., Carver, J. R., Dent, S. F., Ky, B., Lyon, A. R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab674 · Cited by 674 · see citing works

Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency

Fiorentini, D., Cappadone, C., Farruggia, G., & Prata, C. (2021) · Nutrients · doi:10.3390/nu13041136 · Cited by 598 · see citing works

Drugs That May Cause or Exacerbate Heart Failure

Page, R. L., II, O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. M. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 474 · see citing works

Insights into the Problem of Alarm Fatigue with Physiologic Monitor Devices: A Comprehensive Observational Study of Consecutive Intensive Care Unit Patients

Drew, B. J., Harris, P., Zègre-Hemsey, J. K., Mammone, T., Schindler, D., Salas-Boni, R., Bai, Y., Tinoco, A., Ding, Q., & Hu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110274 · Cited by 438 · see citing works

Untitled work

Verrier (2011) · doi:10.1016/j.jacc.2011.06.029 · Cited by 421 · see citing works

Which QT Correction Formulae to Use for QT Monitoring?

Vandenberk, B., Vandael, E., Robyns, T., Vandenberghe, J. U., Garweg, C., Foulon, V., Ector, J., & Willems, R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003264 · Cited by 410 · see citing works

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association

Tisdale, J. E., Chung, M. K., Campbell, K. B., Hammadah, M., Joglar, J. A., Leclerc, J., & Rajagopalan, B. (2020) · Circulation · doi:10.1161/cir.0000000000000905 · Cited by 411 · see citing works

2014 ESC/ESA Guidelines on non-cardiac surgery

Kristensen, S. D., Knuuti, J. M., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. G. D., Ford, I., González‐Juanatey, J. R., Görenek, B., Heyndrickx, G. R., et al. (2014) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000150 · Cited by 406 · see citing works

Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients

Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Mourad, N. A., Trujillo, T. N., Overholser, B. R., & Kovacs, R. J. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000152 · Cited by 391 · see citing works

Magnesium in Aging, Health and Diseases

Barbagallo, M., Veronese, N., & Dominguez, L. J. (2021) · Nutrients · doi:10.3390/nu13020463 · Cited by 379 · see citing works

Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

Sandau, K. E., Funk, M., Auerbach, A. D., Barsness, G. W., Blum, K., Cvach, M. M., Lampert, R., May, J. L., McDaniel, G. M., Perez, M. V., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000527 · Cited by 354 · see citing works

Predicting the Unpredictable

Schwartz, P. J., & Woosley, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.063 · Cited by 329 · see citing works

Drug-induced QT interval prolongation: mechanisms and clinical management

Nachimuthu, S., Assar, M. D., & SCHUSSLER, J. M. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612454283 · Cited by 315 · see citing works

2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry

Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303 · see citing works

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin

Chorin, E., Wadhwani, L., Magnani, S., Dai, M. S., Shulman, E. H., Nadeau‐Routhier, C., Knotts, R. J., Bar-Cohen, R., Kogan, E., Barbhaiya, C. R., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.014 · Cited by 295 · see citing works

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines

Alexandre, J., Cautela, J., Éderhy, S., Damaj, G. L., Salem, J., Barlési, F., Farnault, L., Charbonnier, A., Mirabel, M., Champiat, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018403 · Cited by 296 · see citing works

Cardiovascular Complications of Cancer Therapy

Chang, H., Okwuosa, T. M., Scarabelli, T. M., Moudgil, R., & Yeh, E. T. H. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1095 · Cited by 293 · see citing works

Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium

Krishna, K. B., Fuqua, J. S., Rogol, A. D., Klein, K. O., Popovic, J., Houk, C. P., Charmandari, E., & Lee, P. A. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501336 · Cited by 291 · see citing works

The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias

Curtis, M. J., Hancox, J. C., Farkas, A., Wainwright, C. L., Stables, C. L., Saint, D. A., Clements‐Jewery, H., Lambiase, P. D., Billman, G. E., Janse, M. J., et al. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.008 · Cited by 287 · see citing works

Cardiovascular complications of anorexia nervosa: A systematic review

Sachs, K. V., Harnke, B., Mehler, P. S., & Krantz, M. J. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22481 · Cited by 273 · see citing works

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Bessière, F., Roccia, H., Delinière, A., Charrière, R., Chevalier, P., Argaud, L., & Cour, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1787 · Cited by 271 · see citing works

Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society

Chou, R., Cruciani, R. A., Fiellin, D. A., Compton, P. A., Farrar, J. T., Haigney, M. C., Inturrisi, C. E., Knight, J. R., Otis‐Green, S., Marcus, S. M., et al. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.494 · Cited by 263 · see citing works

QT interval prolongation and the risk of torsades de pointes: essentials for clinicians

Trinkley, K. E., Page, R. L., II, Lien, H., Yamanouye, K., & Tisdale, J. E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.840568 · Cited by 231 · see citing works

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Dan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 234 · see citing works

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

Porta‐Sánchez, A., Gilbert, C. J., SPEARS, D. A., Amir, E., Chan, J., Nanthakumar, K., & Thavendiranathan, P. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007724 · Cited by 221 · see citing works

Risk factors for QTc-prolongation: systematic review of the evidence

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Willems, R., & Foulon, V. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0414-2 · Cited by 212 · see citing works

Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management

Tisdale, J. E. (2016) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163516641136 · Cited by 209 · see citing works

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

Jankelson, L., Karam, G., Becker, M. L., Chinitz, L. A., & Tsai, M. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.008 · Cited by 184 · see citing works

Long QT Syndrome: An Emerging Role for Inflammation and Immunity

Lazzerini, P. E., Capecchi, P. L., & Pasini, F. L. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00026 · Cited by 172 · see citing works

Institution-Wide QT Alert System Identifies Patients With a High Risk of Mortality

Haugaa, K. H., Bos, J. M., Tarrell, R. F., Morlan, B. W., Caraballo, P. J., & Ackerman, M. J. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.013 · Cited by 163 · see citing works

Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association

Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Palo, K. E. D., Okwuosa, T. M., Przespolewski, E. R., & Sj, D. (2022) · Circulation · doi:10.1161/cir.0000000000001056 · Cited by 168 · see citing works

Pharmacological treatment of acquired QT prolongation and torsades de pointes

Thomas, S. H. L., & Behr, E. R. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12726 · Cited by 161 · see citing works

Novel deep learning model for more accurate prediction of drug-drug interaction effects

Lee, G., Park, C., & Ahn, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3013-0 · Cited by 155 · see citing works

AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults

Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C., Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd‐Jones, D. M., Mora, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192617 · Cited by 155 · see citing works

Atrial Fibrillation

Michaud, G. F., & Stevenson, W. G. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2023658 · Cited by 149 · see citing works

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol

Naksuk, N., Lazar, S., & Peeraphatdit, T. B. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872620922784 · Cited by 147 · see citing works

Electroimmunology and cardiac arrhythmia

Grune, J., Yamazoe, M., & Nahrendorf, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00520-9 · Cited by 152 · see citing works

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association

Fradley, M. G., Beckie, T. M., Brown, S.-A. N., Cheng, R. K.-H., Dent, S. F., Nohria, A., Patton, K. K., Singh, J. P., & Olshansky, B. (2021) · Circulation · doi:10.1161/cir.0000000000000986 · Cited by 149 · see citing works

High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality

Pickham, D. M., Helfenbein, E. D., Shinn, J. A., Chan, G. K., Funk, M., Weinacker, A. B., Liu, J., & Drew, B. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232db4a · Cited by 145 · see citing works

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

Pani, A., Lauriola, M., Romandini, A., & Scaglione, F. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106053 · Cited by 136 · see citing works

Magnesium in disease

Geiger, H., & Wanner, C. (2012) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfr165 · Cited by 130 · see citing works

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation

Koenig, X., & Hilber, K. (2015) · Molecules · doi:10.3390/molecules20022208 · Cited by 129 · see citing works

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

Giudicessi, J. R., Schram, M. C., Bos, J. M., Galloway, C. D., Shreibati, J. B., Johnson, P. W., Carter, R. E., Disrud, L. W., Kleiman, R., Attia, Z. I., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050231 · Cited by 130 · see citing works

Drug-Induced QT Prolongation And Torsades de Pointes.

Li, M., & Ramos, L. G. (2017) · PubMed Central · Cited by 124 · see citing works

S2k-Leitlinie: Tuberkulose im Erwachsenenalter

Schaberg, T., Bauer, T. T., Brinkmann, F., Diel, R., Feiterna‐Sperling, C., Haas, W., Hartmann, P., Hauer, B., Heyckendorf, J., Lange, C. G., et al. (2017) · Pneumologie · doi:10.1055/s-0043-105954 · Cited by 121 · see citing works

Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study

Girardin, F. R., Gex‐Fabry, M., Berney, P., Shah, D. C., Gaspoz, J., & Dayer, P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060860 · Cited by 119 · see citing works

Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes

Lazzerini, P. E., Pasini, F. L., Bertolozzi, I., Morozzi, G., Lorenzini, S., Simpatico, A., Selvi, E., Bacarelli, M. R., Finizola, F., Vanni, F., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-311079 · Cited by 119 · see citing works

Chloroquine-induced QTc prolongation in COVID-19 patients

van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., & van de Garde, E. M. W. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01429-7 · Cited by 118 · see citing works

Fir(e)ing the Rhythm

Lazzerini, P. E., Abbate, A., Boutjdir, M., & Capecchi, P. L. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.004 · Cited by 118 · see citing works

2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry

Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P. F., Balsam, P., Baranchuk, A. M., Cantillon, D. J., Dilaveris, P., Dubner, S., El‐Sherif, N., et al. (2017) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12447 · Cited by 118 · see citing works

Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies

Lazzerini, P. E., Capecchi, P. L., El‐Sherif, N., Pasini, F. L., & Boutjdir, M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010595 · Cited by 117 · see citing works

Prevention of complications in the cardiac intensive care unit: a scientific statement from the American Heart Association

Fordyce, C. B., Katz, J. N., Alviar, C. L., Arslanian-Engoren, C., Bohula, E. A., Geller, B. J., Hollenberg, S. M., Jentzer, J. C., Sims, D. B., Washam, J. B., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000909 · Cited by 116 · see citing works

Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator

Klein, H., Goldenberg, I., & Moss, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht167 · Cited by 115 · see citing works

Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias

Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Boutjdir, M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.61 · Cited by 115 · see citing works

A systematic review of the cardiotoxicity of methadone.

Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., & Mehrpour, O. (2015) · EXCLI journal · doi:10.17179/excli2015-553 · Cited by 113 · see citing works

Medical findings in 1,026 consecutive adult inpatient–residential eating disordered patients

Mehler, P. S., Blalock, D. V., Walden, K., Kaur, S., McBride, J., Walsh, K., & Watts, J. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22830 · Cited by 109 · see citing works

Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol

Al‐Qadheeb, N. S., Skrobik, Y. K., Schumaker, G. L., Pacheco, M., Roberts, R. J., Ruthazer, R., & Devlin, J. W. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001411 · Cited by 104 · see citing works

Psychiatric considerations in the oncology setting

Mehta, R. D., & Roth, A. J. L. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21285 · Cited by 103 · see citing works

Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients

Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2013) · Diabetes Care · doi:10.2337/dc13-0701 · Cited by 103 · see citing works

Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12‐Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide

GARABELLI, P., STAVRAKIS, S., ALBERT, M., KOOMSON, E., PARWANI, P., CHOHAN, J., SMITH, L., ALBERT, D., XIE, R., XIE, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12976 · Cited by 98 · see citing works

CredibleMeds.org: What does it offer?

Woosley, R. L., Black, K., Heise, C. W., & Romero, K. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.07.010 · Cited by 99 · see citing works

Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide

Roboz, G. J., Ritchie, E. K., Carlin, R. F., Samuel, M., Gale, L., Provenzano, J. L., Curcio, T. J., Feldman, E. J., & Kligfield, P. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.2913 · Cited by 91 · see citing works

Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients

Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Overholser, B. R., Mourad, N. A., Trujillo, T. N., & Kovacs, R. J. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000651 · Cited by 93 · see citing works

Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes

El‐Sherif, N., Turitto, G., & Boutjdir, M. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2019.8.3 · Cited by 91 · see citing works

Medication Errors in Acute Cardiovascular and Stroke Patients

Michaels, A. D., Spinler, S. A., Leeper, B. “., Ohman, E. M., Alexander, K. P., Newby, L. K., Ay, H., & Gibler, W. B. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4b43e · Cited by 93 · see citing works

Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians

Porta, A. D., Bornstein, K., Coye, A., Montrief, T., Long, B., & Parris, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.07.030 · Cited by 88 · see citing works

Current Perceptions and Practices Surrounding the Recognition and Treatment of Delirium in the Intensive Care Unit: A Survey of 250 Critical Care Pharmacists from Eight States

Devlin, J. W., Bhat, S., Roberts, R. J., & Skrobik, Y. K. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q332 · Cited by 87 · see citing works

Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs

Tisdale, J. E., Wroblewski, H. A., Overholser, B. R., Kingery, J. R., Trujillo, T. N., & Kovacs, R. J. (2012) · Drug Safety · doi:10.2165/11598160-000000000-00000 · Cited by 85 · see citing works

Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs

Kligfield, P., Badilini, F., Denjoy, I., Babaeizadeh, S., Clark, E., de Bie, J., Devine, B., Extramiana, F., Generali, G., Gregg, R. E., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.02.014 · Cited by 85 · see citing works

Acquired long QT syndrome and torsade de pointes

El‐Sherif, N., Turitto, G., & Boutjdir, M. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13296 · Cited by 85 · see citing works

Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome

Prifti, E., Fall, A., Davogustto, G., Pulini, A., Denjoy, I., Funck‐Brentano, C., Khan, Y. W., Durand-Salmon, A., Badilini, F., Wells, Q. S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab588 · Cited by 83 · see citing works

Postoperative QT Interval Prolongation in Patients Undergoing Noncardiac Surgery under General Anesthesia

Nägele, P., Pal, S., Brown, F., Blood, J., Miller, J. P., & Johnston, J. D. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31825e6eb3 · Cited by 83 · see citing works

Cardiac changes in anorexia nervosa

Spaulding-Barclay, M. A., Stern, J. L., & Mehler, P. S. (2016) · Cardiology in the Young · doi:10.1017/s104795111500267x · Cited by 83 · see citing works

Drug-drug interactions contributing to QT prolongation in cardiac intensive care units

Armahizer, M. J., Seybert, A. L., Smithburger, P. L., & Kane‐Gill, S. L. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.10.014 · Cited by 83 · see citing works

Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus

Morgan, N. D., Patel, S. V., & Dvorkina, O. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31829d5e50 · Cited by 80 · see citing works

QT Assessment in Early Drug Development: The Long and the Short of It

Lester, R. M., Paglialunga, S., & Johnson, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061324 · Cited by 80 · see citing works

Cardiac risks associated with antibiotics: azithromycin and levofloxacin

Lu, K., Yuan, J., Li, M., Sutton, S. S., Rao, G., Jacob, S., & Bennett, C. L. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.989210 · Cited by 78 · see citing works

Prolonged corrected QT interval in anti‐Ro/SSA–positive adults with systemic lupus erythematosus

Bourré‐Tessier, J., Clarke, A. E., Huynh, T. T., Bernatsky, S., Joseph, L., Bélisle, P., & Pineau, C. A. (2011) · Arthritis Care & Research · doi:10.1002/acr.20470 · Cited by 78 · see citing works

Development of a risk score for QTc-prolongation: the RISQ-PATH study

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Spriet, I., Willems, R., & Foulon, V. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0446-2 · Cited by 77 · see citing works

Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives

Duan, J., Tao, J., Zhai, M., Li, C., Zhou, N., Lv, J., Wang, L., Lin, L., & Bai, R. (2018) · Oncotarget · doi:10.18632/oncotarget.25008 · Cited by 75 · see citing works

Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression

Lazzerini, P. E., Acampa, M., Laghi-Pasini, F., Bertolozzi, I., Finizola, F., Vanni, F., Natale, M., Bisogno, S., Cevenini, G., Cartocci, A., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008627 · Cited by 74 · see citing works

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

Page, R. L., II, Hafermann, M. J., Namdar, & Seibold (2011) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s25623 · Cited by 74 · see citing works

Drug-induced arrhythmias

Barnes, B. J., & Hollands, J. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de112a · Cited by 73 · see citing works

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Poluzzi, E., Raschi, E., Koci, A., Moretti, U., Spina, E., Behr, E. R., Sturkenboom, M., & Ponti, F. D. (2013) · Drug Safety · doi:10.1007/s40264-013-0032-z · Cited by 70 · see citing works

A current understanding of drug-induced QT prolongation and its implications for anticancer therapy

Roden, D. M. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz013 · Cited by 68 · see citing works

The QT Interval

Giudicessi, J. R., Noseworthy, P. A., & Ackerman, M. J. (2019) · Circulation · doi:10.1161/circulationaha.119.039598 · Cited by 67 · see citing works

Ventricular repolarization measures for arrhythmic risk stratification

Monitillo, F. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i1.57 · Cited by 66 · see citing works

Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature

Meid, A. D., Bighelli, I., Mächler, S., Mikus, G., Carrà, G., Castellazzi, M., Lucii, C., Martinotti, G., Nosè, M., Ostuzzi, G., et al. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317721662 · Cited by 66 · see citing works

Cardiovascular Disease in Women

Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65 · see citing works

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Barnes, T. R. E., Leeson, V. C., Paton, C., Costelloe, C., Simon, J., Kiss, N., Osborn, D., Killaspy, H. T., Craig, T., Lewis, S. W., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20290 · Cited by 65 · see citing works

Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes

Lazzerini, P. E., Yue, Y., Srivastava, U., Fabris, F., Capecchi, P. L., Bertolozzi, I., Bacarelli, M. R., Morozzi, G., Acampa, M., Natale, M., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003419 · Cited by 64 · see citing works

Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit

Naksuk, N., Hu, T. Y., Krittanawong, C., Thongprayoon, C., Sharma, S., Park, J. Y., Rosenbaum, A. N., Gaba, P., Killu, A. M., Sugrue, A. M., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.08.033 · Cited by 64 · see citing works

Association of Implementation of Practice Standards for Electrocardiographic Monitoring With Nurses’ Knowledge, Quality of Care, and Patient Outcomes

Funk, M., Fennie, K., Stephens, K., May, J. L., Winkler, C. G., Drew, B. J., Borman, B., Calcasola, S., Carey, M. G., Currie, L., et al. (2017) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003132 · Cited by 64 · see citing works

Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias

Giudicessi, J. R., Ackerman, M. J., & Camilleri, M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13302 · Cited by 66 · see citing works

Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the

Menon, V., Roden, D. M., Zareba, W., Drew, B. J., Ackerman, M. J., Funk, M., & Gibler, W. B. (2010)

2010 AHA/ACCF Scientific Statement for Prevention of Torsade de Pointes in Hospital Settings

Chong-bai, X. (2011) · Advances in Cardiovascular Diseases

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., Zareba, W., American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, et al. (2010) · eScholarship (California Digital Library) · Cited by 57 · see citing works

Incidence of Torsade de Pointes in a teriary hospital population

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Pincé, H., Willems, R., & Foulon, V. (2016) · Acta Cardiologica

[Torsades de pointes].

Kishi, F., Nomura, M., Saito, K., Ito, S., & Nakaya, Y. (1996) · PubMed